Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Urogynecology Journal
Published in: International Urogynecology Journal 9/2008

01-09-2008 | Original Article

Predicting detrusor overactivity using a physician-based scoring system

Authors: Maria Vella, Dudley Robinson, Linda Cardozo, Sushma Srikrishna, Rufus Cartwright

Published in: International Urogynecology Journal | Issue 9/2008

Login to get access

Abstract

Women with lower urinary tract symptoms (LUTS) commonly present to primary care. Management is often based on a symptomatic diagnosis alone although LUTS correlate with urodynamic diagnosis in 65% of cases. The aim of this study was to develop a scoring system to discriminate between the symptoms of stress urinary incontinence (SUI) and overactive bladder (OAB). Physicians completed a specially developed questionnaire for all women complaining of LUTS. Women then underwent videocystourethrography. A scoring system based on the likelihood of each symptom for DO was developed using odds ratios and 95% confidence intervals (CI). This scoring system was subsequently used to discriminate those women with OAB from those with SUI. One hundred seventy one women were recruited to the study. This scoring system had a sensitivity of 79%, a specificity of 78% and a positive predictive value of 73% to identify detrusor overactivity (DO) This new OAB scoring system may be used in primary care to help discriminate between USI and DO.
Appendix
Available only for authorised users
Literature
1.
Kelleher CJ, Cardozo LD, Khullar V, Salvatore S (1997) A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 104:1374–1379PubMed
2.
Abrams P, Cardozo L, Fall M et al (2002) The standardization of terminology of lower urinary tract function: report from the standardization sub-committee of the International Continence Society. Neurourol Urodyn 21(2):167–178PubMedCrossRef
3.
Andersson K-E (1997) The overactive bladder: pharmacologic basis of drug treatment. Urology 50(6A Suppl):74–84PubMedCrossRef
4.
Jarvis GJ, Hall S, Stamp S, Miller DR, Johnson A (1980) An assessment of urodynamic examination in incontinent women. Br J Obstet Gynaecol 87(10):893–896 OctPubMed
5.
National Institute for Health and Clinical Excellence. Urinary incontinence: the management of urinary incontinence in women. October 2006
6.
Milson I, Abrams P, Cardozo L et al (2001) How widespread are the symptoms of an overactive bladder and how are they managed? A population based prevalence study. BJU Int 87(9):760–766CrossRef
7.
Stewart WF, Van Rooyen JB, Cundiff GW et al (2003) Prevalence and burden of overactive bladder in the United States. World Journal of Urology 20(6):327–336PubMed
8.
Graham CA, Mallett VT (2001) Race as a predictor of urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol 185(1):116–120 JulPubMedCrossRef
9.
Langer R, Lipshitz Y, Halperin R et al (2001) Long term follow up after Burch colposuspension for urinary stress incontinence. Int Urogynecol J Pelvic Floor Dysfunction 12:323–326 discussion 326–7CrossRef
10.
Ahlberg J, Edlund C, Wikkelso C et al (2002) Neurological signs are common in patients with urodynamically verified “idiopathic”bladder overactivity. Neurourol Urodyn 21(1):65–70PubMedCrossRef
11.
Shafer W, Abrams P, Liao L et al (2002) The International Continence Society. Neurourol Urodyn 21(3):261–274CrossRef
12.
13.
Digesu GA, Khullar V, Cardozo L, Salvatore S (2003) Overactive bladder symptoms. Neurourol Urodyn 22(4):105–108PubMedCrossRef
14.
Kelleher CJ, Cardozo L, Khullar V, Salvatore S (1997) A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance. Br J Obstet Gynaecol 104(9):988–993 SepPubMed
15.
Duckett J, Vella M, Kavalakuntla G, Basu M (2007) Tolerability and efficacy of duloxetine in a nontrial situation. BJOG 114(5):543–547 MayPubMedCrossRef
16.
Hashim H, Abrams P (2004) Do symptoms of overactive bladder predict urodynamic detrusor overactivity? Neurourol Urodyn 23:484
Metadata
Title
Predicting detrusor overactivity using a physician-based scoring system
Authors
Maria Vella
Dudley Robinson
Linda Cardozo
Sushma Srikrishna
Rufus Cartwright
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
International Urogynecology Journal / Issue 9/2008
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-008-0607-x

Other articles of this Issue 9/2008

International Urogynecology Journal 9/2008 Go to the issue

Original Article

Correlation between posterior vaginal wall defects assessed by clinical examination and by defecography

Original Article

Physiological effects of human muscle-derived stem cell implantation on urethral smooth muscle function

Case Report

Conservative management of iatrogenic bladder injury with foreign body

Original Article

Pelvic organ prolapse symptoms in relation to POPQ, ordinal stages and ultrasound prolapse assessment

Original Article

Transverse cystocele repair with uterine preservation using native tissue

Original Article

The impact of multichannel urodynamics upon treatment recommendations for female urinary incontinence